Drug Information
| Drug General Information | |||||
|---|---|---|---|---|---|
| Drug ID |
D0Q1YJ
|
||||
| Former ID |
DNCL002330
|
||||
| Drug Name |
RON mab
|
||||
| Drug Type |
Monoclonal antibody
|
||||
| Indication | Cancer [ICD9: 140-229; ICD10:C00-C96] | Phase 1 | [523034] | ||
| Company |
Eli Lilly; ImClone Systems
|
||||
| Target and Pathway | |||||
| Target(s) | RON | Target Info | Inhibitor | [550458] | |
| Pathway Interaction Database | amb2 Integrin signaling | ||||
| a6b1 and a6b4 Integrin signaling | |||||
| References | |||||